An Unbiased View of modafinil
Belzutifan can be a CYP2C19 substrate. Coadministration with CYP2C19 inhibitors could enhance incidence or severity of adverse outcomes. Watch for anemia and hypoxia and reduce belzutifan dose as advisable.modafinil will reduce the level or result of norgestrel by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Careful